Malignant Melanoma

Showing 1 - 25 of 202

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Melanoma, Malignant Melanoma Trial (T3011 + Cobimetinib)

Not yet recruiting
  • Melanoma
  • Malignant Melanoma
  • T3011 + Cobimetinib
  • (no location specified)
Mar 3, 2023

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsense™ VS3 - Stereoscopic High Definition Visualisation System

Completed
  • Malignant Melanoma
  • Merkel Cell Carcinoma
  • Visionsense™ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
  • Bern, Kanton Bern, Switzerland
    Inselspital, University Hospital Bern, University of Bern
Dec 7, 2022

Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

Recruiting
  • Malignant Melanoma
  • +3 more
  • SCIB1 DNA vaccine
  • Cardiff, United Kingdom
  • +6 more
Dec 7, 2022

Malignant Melanoma Trial in United States (UV1, GM-CSF)

Active, not recruiting
  • Malignant Melanoma
  • Santa Monica, California
  • +3 more
Nov 16, 2022

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

Recruiting
  • Malignant Melanoma
  • +2 more
  • Stereotaxic radiosurgery (SRS)
  • +3 more
  • Bobigny, France
  • +20 more
Oct 7, 2022

Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

Recruiting
  • Malignant Melanoma
  • Pembrolizumab Injection [Keytruda]
  • +6 more
  • Herlev, Hovedstaden, Denmark
  • +2 more
Sep 16, 2022

Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +118 more
Aug 22, 2022

Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)

Recruiting
  • Malignant Melanoma
  • UV1
  • +3 more
  • Phoenix, Arizona
  • +39 more
Aug 16, 2022

Malignant Melanoma, Gynecologic Cancer Trial in Pavia (carbon ion radiation therapy CIRT)

Recruiting
  • Malignant Melanoma
  • Gynecologic Cancer
  • carbon ion radiation therapy CIRT
  • Pavia, Italy
    CNAO
Jul 27, 2022

Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Malignant Melanoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

Recruiting
  • Malignant Melanoma
  • dabrafenib + trametinib
  • Coimbra, Center, Portugal
  • +5 more
Jun 9, 2022

Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)

Recruiting
  • Malignant Melanoma
  • Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
  • Aurora, Colorado
    University of Colorado Hospital
May 25, 2022

Skin Cancer, Malignant Melanoma Trial in Copenhagen (Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and

Recruiting
  • Skin Cancer
  • Malignant Melanoma
  • Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and tape-strippng of RNA and lipids
  • Copenhagen, Denmark
    Dept of Dermatology
May 20, 2022

Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

Terminated
  • Malignant Melanoma
  • Brain Metastases
  • Tucson, Arizona
    University of Arizona Cancer Center
Mar 5, 2022

Malignant Melanoma Trial in Milan (Pembrolizumab)

Recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • Milan, Italy
    IEO Istituto Europeo di Oncologia
May 12, 2022

Diagnostic Precision of AI Tool Dermalyzer to Identify Malignant

Recruiting
  • Malignant Melanoma
  • Dermalyzer
  • Linköping, Docent, Sweden
  • +2 more
May 12, 2022

Malignant Melanoma, Sinonasal Melanoma Trial in Shanghai (endoscopic surgery)

Recruiting
  • Malignant Melanoma
  • Sinonasal Melanoma
  • endoscopic surgery
  • Shanghai, Shanghai, China
    Eye& ENT Hospital, Fudan University
May 8, 2022

SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • SCLC
  • +2 more
  • GD2-SADA:177Lu-DOTA Complex
  • (no location specified)
May 4, 2022

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in

Recruiting
  • Non-Small-Cell Lung Carcinoma
  • +3 more
  • Checkpoint Inhibitor, Immune
  • Elizabethtown, Kentucky
    Baptist Health Clinical Research
Apr 25, 2022